IVF Success Rates: Clinic Data, Treatment Choices and Add-on Evidence

Introduction: It’s never just “luck” that affects the success rate of IVF

IVF outcomes vary substantially by age, egg source, diagnosis, embryo stage and clinic. The first task is not to collect every add-on, but to compare patient-relevant outcomes using the same denominator.

This guide separates laboratory quality and indicated treatment from tests, drugs and technologies that are often marketed with stronger success claims than the evidence supports.

Whether you're new to IVF or a patient undergoing treatment, you'll find practical information and advice.

1. Laboratory and embryo quality: the core underlying variable in success rate

The embryonic laboratory is the core battlefield of IVF technology. The laboratory environment, equipment and technical level directly determine the quality of embryo development.

1. Laboratory environmental standards

• Air quality:The embryo laboratory must be equipped with a high-level air purification system (ISO Class 5) to control the content of dust particles and microorganisms in the air to ensure that embryos develop in a sterile environment.
• Temperature and humidity control:The laboratory temperature needs to be stable at around 37°C and the humidity maintained at 50%–60% to provide a stable in vitro living environment for the embryos.
• Gas control:Embryo culture requires specific carbon dioxide (5%–6%) and oxygen (5%) concentrations to simulate the female reproductive tract environment.

2. Advanced equipment and technology

• Time-lapse incubation:It can record embryo development continuously, but current evidence does not show that routine use improves live birth. Equipment marketing should not substitute for laboratory outcome data.
• Dynamic or AI-assisted assessment:It may provide additional information to embryologists, but algorithms require local validation and cannot identify a guaranteed “best embryo.”
• Vitrification:This is an established process, but warming survival depends on embryo stage, laboratory quality and the denominator used. Ask for the clinic's own warming, transferable-embryo and live-birth data rather than relying on a universal “over 95%” claim.

3. Embryologist’s experience

Embryo procedures require qualified staff, identity checks, equipment quality control and stable protocols. Laboratory experience affects process quality, but no individual or device can guarantee success.

2. What information can PGT provide, and how should outcomes be compared?

PGT includes tests with different purposes. PGT-A can provide information about embryo aneuploidy, but ASRM's 2024 committee opinion states that current evidence does not support routine universal PGT-A screening. The decision should be individualized according to egg age, embryo number, prior history, test limitations, biopsy and freeze-thaw considerations, and cost.

PGT-A (Aneuploidy Screening)

• effect:Check whether the number of chromosomes in the embryo is normal.
• Evidence boundary:Outcomes per euploid-embryo transfer do not by themselves show that PGT-A improves cumulative live birth per egg retrieval. Results can also be mosaic, inconclusive, or affected by sampling limitations; testing is not a guarantee of a healthy baby or a successful cycle.
• Decision process:Patients with advanced reproductive age, recurrent loss, or repeated transfer failure can discuss PGT-A with a reproductive specialist and genetic counselor, but none of these factors automatically makes testing mandatory.

PGT-M (single gene disease screening)

• effect:For families with a family history of genetic diseases, the embryos are tested to see if they carry the disease-causing gene.
• Applicable people:Both or one partner of the couple carries genes for genetic diseases (such as cystic fibrosis, thalassemia, hereditary breast cancer BRCA1/2 mutations, etc.).

PGT-SR (Chromosome Structural Variation Screening)

• effect:Detect structural abnormalities such as chromosomal balanced translocations and inversions, screen embryos with normal karyotype, and reduce the risk of miscarriage caused by chromosomal abnormalities.

Source: ASRM, “The use of preimplantation genetic testing for aneuploidy: a committee opinion” (2024).

3. Timing of embryo culture and embryo transfer: place good embryos at the right time

blastocyst culture

A blastocyst is an embryo cultured to about day 5 or 6. Because extended culture has already selected embryos that reached this stage, outcomes per transfer may be higher than for cleavage-stage embryos; that does not prove cumulative live birth per egg retrieval is higher.

• Possible advantage:It can support embryo ranking and single-embryo transfer; multiple-pregnancy risk is reduced by the single-embryo policy, not by blastocyst culture alone.
• Key trade-off:Some patients may have no embryo reach blastocyst and therefore no transfer in that cycle. Age, embryo number and local laboratory data matter.

Ultrasound-guided embryo transfer

Ultrasound guidance can help visualize the catheter path and standardize placement. It cannot ensure a “best position,” implantation or live birth; the approach depends on anatomy and clinic protocol.

Embryo transfer timing selection

Transfer timing is usually based on the cycle protocol, progesterone exposure, ultrasound and clinical records. ERA and similar receptivity tests have not been shown to improve live birth routinely in unselected IVF patients and cannot “ensure the implantation window.”

4. Optimization of ovulation induction program: It is not that the more eggs are retrieved, the better, but the better match.

Commonly used ovulation induction programs

The stimulation plan should reflect age, ovarian reserve, prior response and safety. After repeated failure, review medication and embryology records first; growth hormone, coenzyme Q10 and similar add-ons are not routine and cannot promise better egg quality or live birth.

5. Luteal corpus support and endometrial management: Why is the implantation stage equally critical?

Progesterone support is a standard component of many stimulated or frozen-transfer protocols. Route, dose and duration depend on the cycle; extra medication is not a general implantation booster. ERA should not be used routinely to set transfer timing.

6. After repeated embryo transfer failures, in what direction should the investigation be re-examined?

Add-on evidence: HFEA Treatment add-ons; HFEA Endometrial receptivity testing; ESHRE Add-ons guideline; ASRM Immunotherapy in IVF guideline.

7. Nutrition and diet: Which adjustments really make sense?

Key nutrient supplements

• Folic acid:To prevent fetal neural tube defects, it is recommended to start supplementing 3 months before pregnancy.
• Vitamin D:Correct a documented deficiency according to clinical advice; supplementation is not an implantation guarantee.
• Coenzyme Q10, astaxanthin and L-carnitine:Evidence is insufficient to promise better egg or embryo quality or higher live birth for routine IVF patients.
• Iron and calcium:Supplement according to diet, testing and preconception or pregnancy needs rather than stacking high-dose products.

dietary advice

• High protein diet:Chicken breast, fish, shrimp, eggs, milk, and soy products are helpful for egg development.
• Foods rich in antioxidants:Blueberries, strawberries, pomegranates, grapes, nuts, etc.
• Healthy fats:Olive oil, fish oil, and avocado support hormone synthesis and cell membrane health.
• Avoid processed foods:Reduce the intake of high sugar, high salt, and additives.

8. Exercise and weight management: Stabilizing metabolism is more important than short-term sprints

• Recommended exercises:Brisk walking, jogging, swimming, yoga, Pilates, 3-5 times a week, 30-60 minutes each time, moderate intensity.
• Avoid strenuous exercise:Excessive exercise may affect hormone balance and ovulation.
• BMI control:It is recommended to maintain it between 18.5-24.9, and the body fat rate for women is 20%-30%.

9. Work, rest and sleep: Don’t ignore the impact of recovery ability on endocrine systems

• It is recommended to go to bed at 10-11pm every night and ensure 7-8 hours of sleep.
• Avoid staying up late for a long time - it will affect hormone secretion and ovarian function.
• Avoid using electronic devices before going to bed, meditate or read, and create a quiet, dark, and comfortable sleep environment.

10. Emotion and stress management: Why does long-term anxiety affect the implementation of treatment?

Anxiety and stress can affect quality of life, sleep and treatment adherence, but they should not be blamed as a simple cause of poor egg quality or implantation failure. Support aims to improve wellbeing and decision-making, not guarantee live birth.

• Psychological support:Seek help from a psychological counselor if necessary, or join a support group to communicate with other IVF couples.
• Relaxation techniques:10–20 minutes a day of meditation, deep breathing exercises, yoga.
• Interests and hobbies:Painting, reading, music, etc. can enrich your life and divert your attention.
• Family support:Fully communicate with family members, gain understanding and support, and reduce psychological burden.

11. Environmental exposure avoidance: Which daily risks deserve the most priority?

• Bisphenol A (BPA):Found in plastic products and may affect egg quality - glass or stainless steel containers are recommended.
• Phthalates:Found in perfumes, nail polish, and cosmetics, it may disrupt endocrine systems—choose natural skin care products.
• Heavy metals:Lead, mercury, cadmium, etc. can affect fertility, so avoid exposure to polluted environment.
• New decoration environment:Try to avoid staying in the newly renovated space for a long time.

Conclusion: Judge each decision by live birth, safety and evidence

Core laboratory quality and an individualized protocol matter, but more tests, drugs or devices are not automatically better. Without a clear indication and evidence for patient-relevant outcomes, an add-on should not be marketed as a success-rate booster.

I hope this guide can help every expectant parent scientifically plan IVF treatment, maintain a positive attitude, and welcome the arrival of new life.